All Pharma News
Dyne Therapeutics Q1 2024 Results, Business Highlights

Dyne Therapeutics Q1 2024 Results, Business Highlights
GLOBENEWSWIRE
02 May 2024
Share Share
Dyne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Dyne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
27 Mar 2024
Share Share
Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium

Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
PRESS RELEASE
27 Mar 2024
Share Share
Dyne Therapeutics Announces CEO Transition

Dyne Therapeutics Announces CEO Transition
GLOBENEWSWIRE
25 Mar 2024
Share Share
Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days

Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
GLOBENEWSWIRE
13 Mar 2024
Share Share
Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
05 Mar 2024
Share Share
Dyne Announces Presentations on Initial Data From ACHIEVE Trial in DM1 Patients

Dyne Announces Presentations on Initial Data From ACHIEVE Trial in DM1 Patients
GLOBENEWSWIRE
14 Feb 2024
Share Share
Dyne Therapeutics to Present at February Investor Conferences

Dyne Therapeutics to Present at February Investor Conferences
GLOBENEWSWIRE
01 Feb 2024
Share Share
Dyne Therapeutics Announces Closing of Public Offering of Common Stock

Dyne Therapeutics Announces Closing of Public Offering of Common Stock
GLOBENEWSWIRE
11 Jan 2024
Share Share
Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
GLOBENEWSWIRE
05 Jan 2024
Share Share